beyond anti-pd-1 and anti-ctla-4 in melanoma
Published 3 years ago • 388 plays • Length 2:35Download video MP4
Download video MP3
Similar videos
-
34:37
immunotherapy - pd-1 and beyond - melanoma education symposium, patrick ott md phd
-
3:20
update in anti-ctla4 and anti-pd1 treatment in advanced melanoma
-
1:56
medi5752: novel pd-1/ctla-4 bispecific checkpoint inhibitor for advanced solid tumors
-
29:22
immunotherapy: pd-1 antibodies and beyond- dr. carvajal melanoma education symposium 2014
-
6:13
anti-pd-1 or anti-ctla-4 in first line therapy?
-
1:23
exploring the combination anti-ctla-4 and anti-pd-1 in multiple myeloma post-transplant
-
3:36
medi5752: first-in-human trial of a novel pd-1 and ctla-4 bispecific checkpoint inhibitor
-
7:37
combining immunotherapies: inhibiting the ctla-4 and pd-1 pathways
-
23:02
immunotherapy: moving beyond pd1 and pdl1 inhibitors
-
1:29
targeting beyond pd-1 in melanoma
-
1:09
progress in treatment approaches for patients with melanoma
-
2:07
immune checkpoint inhibitors, the next generation cancer therapy - creative biolabs
-
4:29
anti–pd-1 therapy in metastatic melanoma
-
1:43
dr. topalian on biomarkers for anti- pd-1 therapies in melanoma
-
2:48
combining checkpoint blockade therapies in melanoma
-
9:02
pd1/ ctla4 : upfront or sequentially?
-
6:10
pd-1 and ctla-4 blockade following progression on a pd-1 inhibitor in advanced melanoma
-
10:39
developments with pd1 and immunotherapy in melanoma
-
32:38
anti- pd1 treatment in advanced melanoma